Pain Management Market Analysis and Reports | UK Conference Series

Market Analysis - Pain Management 2017

Pain Management 2017 provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solution adopted in the fields.

Pain Management 2017 is an international platform for presenting research about Pain Management and related fields thus contributes to the dissemination of knowledge for the benefit of both the academia and business. This event brings together the top professionals in the field along with the highly affiliated professors to explore the advancements and latest applications achieved in the field of Pain Research. Pain Management 2017 discusses various fields of Pain Management employed in theoretical, practical, surgical fields which mark the support for the advanced and much needed research by their study on various topics. The scientific program will focus on current advances in the research and emerging trends in Pain Management.

Why London

The presence of universities, hospitals, legal/accounting and other professional services, together with key installations of the U.K. make it favourite destination for scientific meetings. London is a leading global city in the arts, commerce, education, finance, healthcare, media, professional services, research and development, tourism, and transport.

The London economy is dominated by four major sectors: oil/gas and related activities, tourism, the port and ship/boat building, and aerospace manufacturing. Boasting attractions such as its magnetic French Quarter and river-boat gambling, London has a history of solid tourist trade. In a city with more than 10 million visitors annually, the hospitality business supplies more than 66,000 jobs in the service sector such as accommodations and restaurants. In 2010, tourists spent $6.9 billion in London.

Why to attend

 With associates from around the world engrossed on learning about Pain Research and advanced Pain Management techniques this can be the best opportunity to reach the largest congregation of participants. Conduct demonstrations, sharing information, meet with current and potential customers, make a splash with a new product line, and receive great acknowledgment at this 2-day event. World-renowned speakers, the most recent techniques and the newest updates in fields are promises of this conference.

Target Audience

 Pharmacologist, Orthopaedist,  Rheumatologist, Pharmacologist, Orthopaedist,  Rheumatologist   Researchers, Pharmacists, Physiotherapist, Neurologist, Pain Management Doctors, Professors, Presidents, Oncologist, Acupuncturist,  Anesthesiologist-Pain Specialist, Medical Doctors, Drug Developers, Rehabilitation Doctors, Students From academe within the Study Of Pain Management And Pain Medicine.

Market Analysis:

The global pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The market is growing at a moderate growth rate, driven by the cancer pain, low back pain and post-operative pain relief markets. In 2010, the global pain management therapeutics market was estimated at $28.6 billion, representing a CAGR of 5.3% between 2002 and 2010. The post-operative pain relief market, with sales of $5.9 billion in 2010, accounted for one fifth of the total pain management therapeutics market. The low back pain market, with sales of $4.9 billion, was the second largest market segment, with a share of 17% of the worldwide pain management therapeutics market. The low back pain market is followed by the cancer pain and neuropathic pain relief markets, accounting for 16% each of the global pain management therapeutics market.

The global pain management market is driven by anticonvulsant Lyrica and anti-depressant Cymbalta, which are expected to expire in 2013. By 2017, the global pain management therapeutics market is forecast to generate sales of $35.1 billion, representing a CAGR of 3.0% between 2010 and 2017. Other blockbuster drugs that are likely to drive the market in the forecast period include UCB Group’s Vimpat (lacosamide), Teva’s Fentora (fentanyl), J&J’s Nucynta (tapentadol), Pfizer’s Remoxy (oxycodone hydrochloride) and Orexo’s Abstral (fentanyl).

Pain management is a stream of medical sciences that eases the suffering of patients who have chronic pain. The global medical devices market is expected to grow at a CAGR of 7.1% between 2012 and 2017 with revenue of $303 billion, by 2017. The pain management devices market is expected to grow at a respectable rate. Pain management has gained significance over the last few years as it eases the sufferings of patients, which is the key driver for the market growth. For example, tech giant Google has entered the pain management market to develop smart contact lenses to monitor glucose levels in diabetic patients. This will save the patients from the pain of pricking their fingers for blood glucose test. 

The global pain management devices market is valued at an estimated USD 3.08 Billion in 2016 and is projected to grow at a CAGR of 8.5% during the forecast period of 2016 to 2021. A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restraining the growth of the global market.

 

Major Associations in London

The British Pain Society

Trigeminal Neuralgia Association

The Royal Society of Medicine

Neuromodulation Society of UK

London Pain Forum

London Society of Regional Anaesthetists

Arthritis Society

The British Medical Acupuncture Society

The National Osteoporosis Society

Australian Pain Society

The UK Gout Society